Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy
=====================================================================================================================================================

* Jared R. Lowe
* Daniel J. Perry
* April K. S. Salama
* Clayton E. Mathews
* Larry G. Moss
* Brent A. Hanks